openPR Logo
Press release

Pharmaceutical Excipients Market to be at Forefront by 2024

07-16-2018 07:47 PM CET | Health & Medicine

Press release from: Transparency Market Research

Pharmaceutical Excipients Market to be at Forefront by 2024

With the pharmaceuticals market comfortably poised to reach annual revenues of US$400 bn before the end of 2020 (according to the World Health Organization), the demand for excipients is expected to exhibit steady growth. This report creates a holistic perspective of the current dynamics that govern the global Pharmaceutical Excipients Market. How the tightening grip of regulators over the excipients used in the market will impact manufacturers and vendors is also assessed. Analysts have also evaluated the projected impact of disruptive drug delivery techniques on those in the business of pharmaceutical excipients.

A pharmaceutical excipient is a substance-either natural or synthetically formulated-that serves multiple purposes in a medicines and drugs. It is used as a bulking or stabilizing substance, as an agent to enhance the solubility of a drug, or as an ingredient that enhances the therapeutic effect of a drug.

There are also some excipients that may lend more value during the manufacturing or handling process of a drug or medicine. Excipients are also used in applications where the in-vitro integrity and stability of drugs need to be preserved. The type and volume of excipient added to a pharmaceutical formulation depends largely on whether the drug is to be administered orally or intravenously. Since certain excipients may effect an undesirable chemical reaction when used alongside an active ingredient or in a certain environment, the selection of the excipient needs to be made carefully.

Global Pharmaceutical Excipients Market: Drivers, Restraints and Trends

Although excipients are used in chemicals and food and beverage sector as well, their use is very closely regulated in the pharmaceutical sector. This puts considerable pressure on manufacturers of pharmaceutical excipients who have to follow numerous process-related and regulatory procedures to bring their products to the market. Besides this factor, a slight but steady decline in the investment inflow in pharmaceutical R&D projects could act against the growth of the global pharmaceutical excipients market.

While these two restraints remain a major concern, the scenario is anything but gloomy for companies operating in the global pharmaceutical excipients market. As companies strive to improve the efficacy and delivery of drugs, new opportunities are bound to emerge even in the pharma excipients space. For instance, the rising interest in nanotechnology in drug delivery and endeavors to reduce the toxicity of drugs are initiatives that will pave the way for the use of innovative excipients.

Opportunities in the global pharmaceutical excipients market are primarily centered on the growing scientific understanding of functionality excipients.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12662

Global Pharmaceutical Excipients Market: Segmentation

If broadly classified according to type, the global market for pharmaceutical excipients can be segmented into organic and inorganic. Carbohydrates and petrochemicals are the two main classes of organic excipients. Inorganic excipients include such substances as metal oxides, calcium carbonates, calcium phosphates, and halites.

Excipients can be used in different types of drug formulation, including but not limited to: oral formulation such as capsules and tablets, parenteral drugs, topical application drugs, and advanced drug delivery systems. The use of excipients in oral drug administration has traditionally been the highest and continues to stay so. Topical drugs are infusing new growth into the global pharmaceutical excipients market.

Based on functionality, pharmaceutical excipients serve as flavoring agents, binders, coatings, preservatives, viscosity agents, lubricants, and more.

Global Pharmaceutical Excipients Market: Region-wise Outlook

Europe has a sizeable pharmaceuticals excipients market, which is also among the largest in the world. North America follows Europe in terms of the size of the excipients market. Globally, Asia Pacific is yet another sizeable pharmaceutical excipients market.

Organizations such as the International Pharmaceutical Excipient Councils function on the global and regional level to promote the proper and safe usage of pharma excipients. Among the key companies operating in the global pharmaceutical excipients market are: BASF SE, Evonik Industries AG, Ashland, Inc., Archer Daniels Midland Company, Croda International Plc.

View Report -

https://www.transparencymarketresearch.com/pharmaceutical-excipients-market.html

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmaceutical Excipients Market to be at Forefront by 2024 here

News-ID: 1128527 • Views:

More Releases from Transparency Market Research

Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive AI Adoption and Next-Generation Edge Computing Innovations | TMR
Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive A …
The global Neuromorphic Chip Market is entering a defining phase of exponential growth, propelled by a surge in artificial intelligence (AI) applications, edge computing expansion, and rapid advancements in next-generation semiconductor technologies. According to the latest industry analysis, the market-valued at US$ 56.2 Mn in 2023-is projected to expand at an extraordinary CAGR of 40.1% from 2024 to 2034, reaching an estimated US$ 2.3 Bn by 2034. Examine key highlights and
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological Disease Burden Accelerates | TMR
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological …
The global Neuroprotection Market continues to gain unprecedented momentum as healthcare systems worldwide intensify their focus on combating neurological disorders. With a valuation of US$ 31.6 Bn in 2022, the market is on track to reach US$ 60.1 Bn by 2031, expanding at a robust 7.5% CAGR during the forecast period. The rise in dementia, stroke, Parkinson's, epilepsy, and multiple sclerosis-combined with aging demographics and a surge in sedentary lifestyles-has
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Innovations in Gene Editing, Stem Cell Therapy, and AI-Based Neuromedicine | TMR
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Inn …
The global neuroregeneration therapy market continues to chart steady, sustained growth. The increasing incidence of neurological disorders-including Alzheimer's disease, Parkinson's disease, multiple sclerosis, Huntington's disease, stroke, diabetic neuropathy, and spinal cord injuries-is significantly influencing market expansion. In 2023, the market was worth US$ 37.0 Bn, demonstrating rising demand for treatments capable of repairing or regenerating damaged neural tissue. Examine key highlights and takeaways from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86322 With breakthroughs
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Advances in Brain Mapping, AI, and Portable Neuroimaging | TMR
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Adv …
The global neuroscience market stood at US$ 30.1 Bn in 2022, reflecting the significant technological and clinical potential of neurological research. Projected to grow at a CAGR of 3.7% from 2023 to 2031, the industry is expected to reach US$ 41.6 Bn by 2031. Rising prevalence of neurodegenerative diseases, advancements in neuroimaging, integration of artificial intelligence, and the emergence of brain-computer interfaces are shaping the next decade of neuroscience innovation. Examine

All 5 Releases


More Releases for Excipient

Chronic Disease Rise Fuels Albumin Excipient Market Growth: The Driving Engine B …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Albumin Excipient Market Size Growth Forecast: What to Expect by 2025? The size of the albumin excipient market has been witnessing significant growth in recent years. It is estimated to rise from $4.85 billion in 2024 to $5.15 billion in 2025 with a Compound Annual Growth Rate (CAGR) of
Biological Excipient Market Key Drivers for 2025
The Biological Excipient market is a crucial segment of the pharmaceutical industry, providing essential support for the efficacy and stability of drug formulations. Biological excipients are naturally derived substances that facilitate the delivery of active pharmaceutical ingredients (APIs), ensuring that medications retain their intended therapeutic effects while enhancing patient compliance and safety. The relevance of this market spans a wide range of applications, including oral and topical formulations, which cater
Biopharmaceutical Excipient Market Growth Fueled by Rising Biologics Demand.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biopharmaceutical Excipient Manufacturing Market- by Type of Biologics (Antibodies, Vaccines, Cell Therapies and Other Biologics), Type of Excipient (Carbohydrates, Polymers, Solubilizers/Surfactants, Polyols, Proteins/Amino Acids and Others), Scale of Operation (Preclinical, Clinical and Commercial), Trends, Industry Competition Analysis, Revenue and Forecast To 2030." According to the latest research by InsightAce Analytic, the global Biopharmaceutical Excipient Manufacturing market
Biopharmaceutical Excipient Manufacturing: Driving Efficiency in Pharmaceutical …
"Biopharmaceutical Excipient Manufacturing Market" in terms of revenue was estimated to be worth $1,372.7 Mn in 2023 and is poised to reach $2,892.5 Mn by 2031, growing at a CAGR of 9.82% from 2024 to 2031 according to a new report by InsightAce Analytic. Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1197 Market Analysis: Biopharmaceutical excipients serve an important role in biologic drug formulation by stabilizing, delivering, and improving the performance of active pharmaceutical
Isotope-Labeled Excipient Market Revenue, Insights, Overview, Outlook, Analysis
Isotope-Labeled Excipient Market Isotopic labeling is a technique which identifies drug products and detects counterfeits. Over the globe, pharmaceutical companies face a major problem of drug counterfeit, and the adoption of isotope-labeled excipients helps in reducing such products which are either manufactured with no active pharmaceutical ingredients (API), wrong API, or an incorrect amount of API. Counterfeiting issues are a major concern in the pharmaceutical market owing to poor regulatory scenario,
Global Pharmaceutical Excipient Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pharmaceutical Excipient Market is projected to grow from USD 8.6 Billion in 2022 to USD 11.5 billion in 2027 at a CAGR of 5.9% from 2022 to 2027. The increase in demand for oral solid pharmaceutical drugs, the emergence of novel therapeutics on account of the growing number of pharmaceutical companies, the rapidly growing pharmaceuticals market, and